Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2002-03-06
2008-12-02
Desai, Anand U (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S391700
Reexamination Certificate
active
07459431
ABSTRACT:
The invention relates to compositions suitable for plasma substitution comprising as a plasma expander a recombinant gelatin-like protein. Characteristic is that the gelatin-like protein essentially is free of hydroxyproline. This absence of hydroxyproline prevents the composition from gelling and thus allows the use of high-molecular weight proteins in order to establish a suitable colloid osmotic pressure. Specific advantage of the gelatin-like proteins is that these avoid the risk of anaphylactic shock that exists in conjunction with the use of commercially available preparations.
REFERENCES:
patent: 3984391 (1976-10-01), Nitschmann et al.
patent: 2005/0101531 (2005-05-01), Bouwstra et al.
patent: WO 01/34646 (2001-05-01), None
Nahas, G. et al. Prog. Clin. Biol. Res. 19: 259-264 (1978).
Haemaccel package insert (published Aug. 28, 1992).
Wootton, J., “Non-globular domains in protein sequences: automated segmentation using complexity measures”, Computers Chem. vol. 18, No. 3, pp. 269-285, 1994.
Bouwstra Jan Bastiaan
Toda Yuzo
Desai Anand U
Fuji Film Manufacturing Europe B.V.
K&L Gates LLP
LandOfFree
Recombinant gelatin-like proteins for use as plasma expanders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant gelatin-like proteins for use as plasma expanders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant gelatin-like proteins for use as plasma expanders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4036808